Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GT Biopharma Inc
(NQ:
GTBP
)
2.184
-0.006 (-0.28%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about GT Biopharma Inc
GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer
December 14, 2022
From
GT Biopharma, Inc.
Via
GlobeNewswire
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022
December 12, 2022
From
GT Biopharma, Inc.
Via
GlobeNewswire
GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
November 10, 2022
From
GT Biopharma, Inc.
Via
GlobeNewswire
GT Biopharma to Present New Data on Novel Dual-Antigen Targeting Approach Against AML at Upcoming 2022 ASH Annual Meeting
November 03, 2022
From
GT Biopharma, Inc.
Via
GlobeNewswire
GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update
October 31, 2022
From
GT Biopharma, Inc.
Via
GlobeNewswire
GT Biopharma Announces Adjournment of Special Shareholders Meeting
October 04, 2022
From
GT Biopharma, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.